Product Information
LEVALBUTEROL 1.25 MG/3 ML SOL is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3897 per ML under NDC 00093414856. Its NADAC has been published 385 times since May 22, 2019.
FDA first approved this application on Apr 26, 2013. Its Orange Book therapeutic-equivalence code is AN.
Strength
1.25 mg/3mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093414856
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
LEVALBUTEROL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090297FDA Approved
4/26/2013
TE Code
AN
On Market Since
4/29/2013
Pharmacological Classes
Price Statistics
The NADAC for LEVALBUTEROL 1.25 MG/3 ML SOL has been published 385 times since May 22, 2019, and over the history we have for it it has risen 17.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3897 per ML |
|---|---|
| All-time high | $0.4736 (Dec 15, 2021) |
| All-time low | $0.1773 (Nov 20, 2024) |
| 52-week high | $0.4370 |
| 52-week low | $0.3897 |
| Median price | $0.3949 |
| Average price | $0.3896 |
| Largest weekly change | +65.2% (Dec 18, 2024) |
| Weeks tracked | 385 |
| Tracking since | May 22, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levalbuterol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVALBUTEROL 1.25 MG/3 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for LEVALBUTEROL 1.25 MG/3 ML SOL, manufactured by Teva Pharmaceuticals USA Inc., is $0.3897 per ML (NDC 00093414856), effective Sep 30, 2026.
How has the price of LEVALBUTEROL 1.25 MG/3 ML SOL changed over time?
Over the history we have for it, the NADAC for LEVALBUTEROL 1.25 MG/3 ML SOL has risen 17.8%. It has been tracked across 385 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for LEVALBUTEROL 1.25 MG/3 ML SOL?
Since May 22, 2019, the NADAC for LEVALBUTEROL 1.25 MG/3 ML SOL has ranged from a low of $0.1773 (Nov 20, 2024) to a high of $0.4736 (Dec 15, 2021), with a median of $0.3949 per ML.
Are there cheaper alternatives to LEVALBUTEROL 1.25 MG/3 ML SOL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVALBUTEROL 1.25 MG/3 ML SOL, is $0.2731 per ML — about 30% below LEVALBUTEROL 1.25 MG/3 ML SOL.
Who manufactures LEVALBUTEROL 1.25 MG/3 ML SOL?
LEVALBUTEROL 1.25 MG/3 ML SOL (NDC 00093414856) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.